Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 3
2003 1
2004 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

5 results
Results by year
Filters applied: . Clear all
Page 1
A controlled trial of natalizumab for relapsing multiple sclerosis.
Miller DH, Khan OA, Sheremata WA, Blumhardt LD, Rice GP, Libonati MA, Willmer-Hulme AJ, Dalton CM, Miszkiel KA, O'Connor PW; International Natalizumab Multiple Sclerosis Trial Group. Miller DH, et al. Among authors: willmer hulme aj. N Engl J Med. 2003 Jan 2;348(1):15-23. doi: 10.1056/NEJMoa020696. N Engl J Med. 2003. PMID: 12510038 Free article. Clinical Trial.
Randomized multicenter trial of natalizumab in acute MS relapses: clinical and MRI effects.
O'Connor PW, Goodman A, Willmer-Hulme AJ, Libonati MA, Metz L, Murray RS, Sheremata WA, Vollmer TL, Stone LA; Natalizumab Multiple Sclerosis Trial Group. O'Connor PW, et al. Among authors: willmer hulme aj. Neurology. 2004 Jun 8;62(11):2038-43. doi: 10.1212/01.wnl.0000128136.79044.d6. Neurology. 2004. PMID: 15184611 Clinical Trial.